Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative nucleos(t)ide analogue therapy for HBV-related hepatocellular carcinoma
ChiCTR-TRC-08000172Phase 3Completed
- Sponsor
- Third Affiliated Hospital of Naval Medical University
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lamivudine, adefovir dipivoxil and entecavir in hepatocellular carcinoma (HCC) and hepatitis B (HBV) (2 arms), sponsored by Third Affiliated Hospital of Naval Medical University. Primary endpoints: Liver function, Blood routine and 7 more. Started Dec 2005; status: completed.
02
Drugs
lamivudineadefovir dipivoxilentecavir
03
Conditions
hepatocellular carcinoma (HCC)hepatitis B (HBV)
Beyond the preview
Go deeper on ChiCTR-TRC-08000172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000172.